CD4 and neoplasm: The release of DAMPs results in increase in serum lympohocytes and incites CD4+ and CTLs and NK cells in tumour parenchyma, which shift the scale of balance towards an anti-tumour immune response rather from an tumour suppressive state [137] (Figure 3).